Oncological outcomes of patients with inflammatory bowel disease undergoing segmental colonic resection for colorectal cancer and dysplasia: systematic review
- PMID: 38822726
- PMCID: PMC11143477
- DOI: 10.1093/bjsopen/zrae052
Oncological outcomes of patients with inflammatory bowel disease undergoing segmental colonic resection for colorectal cancer and dysplasia: systematic review
Figures
References
-
- Kabir M, Fofaria R, Arebi N, Bassett P, Tozer PJ, Hart AL et al. Systematic review with meta-analysis: IBD-associated colonic dysplasia prognosis in the videoendoscopic era (1990 to present). Aliment Pharmacol Ther 2020;52:5–19 - PubMed
-
- Laine L, Kaltenbach T, Barkun A, McQuaid KR, Subramanian V, Soetikno R. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology 2015;148:639–651.e28 - PubMed
-
- Gearhart SL, Nathan H, Pawlik TM, Wick E, Efron J, Shore AD. Outcomes from IBD-associated and non-IBD-associated colorectal cancer: a Surveillance Epidemiology and End Results Medicare study. Dis Colon Rectum 2012;55:270–277 - PubMed
-
- Birch RJ, Burr N, Subramanian V, Tiernan JP, Hull MA, Finan P et al. Inflammatory bowel disease-associated colorectal cancer epidemiology and outcomes: an English population-based study. Am J Gastroenterol 2022;117:1858–1870 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical